JAIME DUVALL: Open Payments
NPI 1295183010 · FRANKLIN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$581 in 34 payments from 8 companies in 2025. Trend: 2023 $76 · 2024 $531 · 2025 $581
Food & beverage: $581
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $261 |
| Novo Nordisk Inc | 5 | $82 |
| PFIZER INC. | 3 | $59 |
| Xeris Pharmaceuticals, Inc. | 3 | $56 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| W. L. Gore & Associates, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $17 |
Products named: VRAYLAR, Rybelsus, ELIQUIS, KEVEYIS, SHINGRIX, UBRELVY, QULIPTA, BREZTRI.
Industry payments across KY — which companies pay providers there.
